arrow
T

Ted R. Mikuls

department of internal medicine
H指数:79
被引数:2.5万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Beyond the Prevention of Anti-drug Antibody Formation with Uricase Therapy: Mechanistic Roles of DMARDs in Modifying Gout Flare Risk

超越尿酸酶疗法预防抗药抗体形成:改善痛风发作风险的DMARDs机制作用

2026-09-140
OAAI
Targeted Treatment for Hyperuricemia: The Drug Pipeline

靶向治疗高尿酸血症:药物研发管线

2026-07-010
PRE
Frailty Predicts Incident Osteoporotic Fractures in Veterans with Rheumatoid Arthritis

虚弱可预测类风湿关节炎退伍军人中新发骨质疏松性骨折

2026-06-220
PREAI
Treat-to-Target Urate-lowering Therapy: Lessons Learned from the STOP Gout Study

目标治疗降尿酸疗法:来自STOP痛风研究的经验教训

2026-04-270
PRE
Inhalant Exposures and the Risk of Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease

吸入性暴露与类风湿关节炎及类风湿关节炎相关间质性肺疾病的风险

2026-04-210
PRE
Inferring rheumatoid arthritis disease activity status from the electronic health records across health systems

从跨医疗系统的电子健康记录中推断类风湿关节炎疾病活动状态

2026-04-130
OAAI
Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset

老年类风湿关节炎(RA)患者接受生物制剂或靶向合成DMARDs治疗时的严重感染风险:发病年龄的作用

2026-03-250
PRE
Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid Arthritis

类风湿关节炎中预测心血管疾病事件风险的计算器的性能

2026-02-170
OAAI
Combining Three Peripheral Blood Biomarkers to Stratify Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk

联合三种外周血生物标志物对类风湿关节炎相关间质性肺疾病风险进行分层

2026-02-010
OAAI
Burden of Disease and Drug Response for Patients With Rheumatoid Arthritis by Shared Epitope and Anticitrullinated Protein Antibody Status

类风湿关节炎患者的疾病负担和药物反应与共享表位和抗瓜氨酸化蛋白抗体状态的关系

2026-02-010
PRE
Characteristics and long-term outcomes of patients with rheumatoid arthritis and concurrent calcium pyrophosphate deposition disease

类风湿关节炎合并焦磷酸钙沉积病患者的特征及长期预后

2025-12-290
OAAI
High Disease Activity is Associated with Incident Osteoporotic Fractures Among Veterans with Rheumatoid Arthritis

高疾病活动度与类风湿关节炎退伍军人中新发骨质疏松性骨折相关

2025-12-170
OAAI
Malondialdehyde-acetaldehyde modified macromolecules and resulting autoantibodies in rheumatoid arthritis pathogenesis: a Systematic Literature Review

丙二醛-乙醛修饰的大分子及其在类风湿关节炎发病机制中产生的自身抗体:系统文献综述

2025-11-240
OAAI
Citrullinated and Malondialdehyde–Acetaldehyde-Modified Fibrinogen Activates Macrophages and Promotes Coronary Endothelial Cell Inflammation

瓜氨酸化和丙二醛-乙醛修饰的纤维蛋白原激活巨噬细胞并促进冠状动脉内皮细胞炎症

2025-11-180
OAAI
Mortality in US Veterans with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors (ICIs)

美国接受免疫检查点抑制剂(ICIs)治疗的类风湿关节炎退伍军人死亡率

2025-11-100
PRE
Frailty carries an increased risk of death in rheumatoid arthritis

虚弱会增加类风湿关节炎患者的死亡风险。

2025-11-070
PRE
Financial Distress and its Determinants in Rheumatoid Arthritis

类风湿关节炎中的财务困境及其决定因素

2025-10-160
OAAI
Performance of an Idiopathic Pulmonary Fibrosis Derived Multibiomarker Panel for Rheumatoid Arthritis-Associated Interstitial Lung Disease

特发性肺纤维化衍生多生物标志物组合在类风湿关节炎相关间质性肺疾病中的表现

2025-09-160
OAAI
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

羟氯喹在类风湿关节炎风险个体中的2期临床试验

2025-08-290
OAAI
Risk and Temporal Trends of Heart Failure Subtypes in Rheumatoid Arthritis

类风湿关节炎中心力衰竭亚型的风险及时序趋势

2025-08-140
PRE